Iohexol Imax

Iohexol, the active ingredient in Iohexol Imax, is an iodinated contrast agent presented as a solution for injection for intra‑arterial and intravenous use. It enhances radiographic visibility during diagnostic imaging procedures in patients undergoing angiography, CT, urography, or arthrography.

GNH USA supplies Iohexol Imax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iohexol is used as an iodinated contrast medium to improve visualization of vascular and tissue structures in diagnostic imaging.

Angiography: provides enhanced vessel delineation for accurate assessment. Computed tomography (CT) imaging: increases contrast between organs and vessels for detailed cross‑sectional images. Urography: highlights urinary tract anatomy to detect obstruction or lesions. Arthrography: improves joint space visualization for orthopedic evaluation.

Adverse reactions may occur following administration of Iohexol.

Common Side Effects: - Warm or flushing sensation at the injection site. - Nausea or vomiting. - Headache. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiovascular collapse or severe hypotension.

Prior to using Iohexol, several safety considerations should be observed.

- Assess renal function: evaluate serum creatinine and eGFR before administration. - Review allergy history: avoid in patients with known hypersensitivity to iodinated contrast. - Ensure adequate hydration: maintain fluid balance to reduce risk of contrast‑induced nephropathy. - Pregnancy considerations: use only when benefits outweigh potential risks (Category B). - Pediatric use: dose adjustment and careful monitoring are required. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iohexol may interact with other medications or agents.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents. - Co‑administration with high‑dose nephrotoxic drugs such as aminoglycosides or NSAIDs. - Recent radioactive iodine therapy.

Moderate Interactions (Monitor Closely): - Diuretics: may increase risk of renal impairment. - ACE inhibitors or ARBs: monitor blood pressure and renal function. - Beta‑blockers: observe for potential hemodynamic changes.